-
FES PET/CT in Endocrine Refractory Breast Cancer
Patients with recurrent or metastatic ER+ breast cancer, who have failed prior endocrine therapy may be eligible for this study ...
David Mankoff See if you qualify
-
Supplement Screening for Breast Cancer with Abbreviated MRI for Black Women with Increased Breast Density
It is well known that black women develop breast cancers which present not only at an earlier age when breasts ... -
The Cancer of the Pancreas Screening-5
The specific Aims of CAPS5 will be: Aim #1: To evaluate pancreatic fluid mutations and circulating pancreatic epithelial cells as ...
Bryson Katona
-
A DOUBLE BLIND RANDOMIZED VEHICLE CONTROLLED CROSSOVER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TOPICAL NALOXONE HYDROCHLORIDE LOTION 0 ...
This application is a request to execute a reliance agreement with Chesapeake an external IRB This study is being done ...
Jennifer Villasenor-Park
-
Preliminary Evaluation of Septin9 in Familial Adenomatous Polyposis Patients
The purpose of this research study is to collect blood samples and applicable medical history from subjects diagnosed with hereditary ...
Anil Rustgi
-
Radiation Oncology Registry
You are being asked to participate in the Radiation Oncology Registry. Participation in this study requires no additional obligations on ...Jay Dorsey
-
Evaluation of Vascular Health Profile in Predicting Venous Thromboembolism
The main goal of this study is to utilize previously validated cytometric markers of to identify cancer patients at high ...
Emile Mohler
Elizabeth Medenilla
-
Mild Hypofractionation using Proton Therapy or IMRT for Low- and Intermediate-Risk Prostate Cancer
This is a study to first establish feasibility of the study and then to register the treatment data of adult ...
Neha Vapiwala
-
UPCC 05122: A Randomized Open-label Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physicians Choice in Patients With Previously ...
The purpose of this study is to see if sacituzumab govitecan can improve lifespans of patients with advanced TNBC and ...
Payal Shah
-
UPCC 15820: A Phase 3 Randomized Placebo-controlled Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone ...
The purpose of this study is to see if niraparib added to a standard treatment (abiraterone acetate and prednisone) will ...
Showing - of trials